VJOncology is committed to improving our service to you

BOPA/ISOPP 2019 | Audit of rapid infusion of biosimilar rituximab

VJOncology is committed to improving our service to you

Calum Polwart

Calum Polwart, County Durham & Darlington NHS Foundation Trust, Durham, UK, discusses his work on a multi-center audit of the rapid infusion of biosimilar rituximab in patients with hematological malignancies. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.

Share this video  
10th October 2019

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter